Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.
Journal: Anti-cancer agents in medicinal chemistry
Published: June 13, 2013
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.
Journal: ChemMedChem
Published: April 23, 2013
Showing 1-2 of 2
Last Updated: 09/26/2026